Sstcipsgqpcpynenccsqsctykenengntvkrcd

Sstcipsgqpcpynenccsqsctykenengntvkrcd

SCHEMBL29838759

CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NPY2R P49146 8/20 0.67
▸ NPY4R P50391 8/20 0.67
▸ NPY5R Q15761 8/20 0.67
▸ NPY1R P25929 6/20 0.67
▸ CALCR P30988 4/20 0.61
▸ EP300 Q09472 1/20 0.61
▸ HIF1A Q16665 1/20 0.61
▸ TFPI P10646 4/20 0.60
▸ KDM1A O60341 2/20 0.59
▸ MAOB P27338 1/20 0.59
▸ KDM5A P29375 1/20 0.59
▸ KDM1B Q8NB78 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Savcipsgqpcpyskyccsgsctyktnengnsvqrcd SCHEMBL29838758 0.98 NPY2R (0.69) NPY2RNPY4RNPY5RNPY1RCALCR
Sptcipsgqpcpynenccsqsctfkenengntvkrcd SCHEMBL29695388 0.97 NPY2R (0.65) NPY2RNPY4RNPY5RNPY1RCALCR
Cipsgqpcpynenccsqsctfkenengntvkrcd SCHEMBL29993310 0.94 NPY2R (0.64) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30712939 0.92 EP300 (0.67) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31020752 0.91 NPY2R (0.64) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182662 0.91 NPY2R (0.68) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30658265 0.91 NPY2R (0.70) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31174223 0.90 NPY2R (0.64) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31182982 0.90 NPY2R (0.73) NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30432502 0.90 NPY2R (0.67) NPY2RNPY4RNPY5RNPY1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042807-A1 NEXT GENERATION ACTX PEPTIDES Vestaron Corporation (US) 2026-02-12 — — US disclosed
US-20250115647-A1 HV1 MODULATORS AND USES UNIV CALIFORNIA (US) 2025-04-10 — — US disclosed
US-12084481-B2 HV1 modulators and uses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-09-10 — — US disclosed
US-20240076327-A1 PESTICIDAL HEXATOXIN POLYPEPTIDES AND METHODS OF USE THEREOF SYNGENTA CROP PROTECTION AG (CH) 2024-03-07 — — US disclosed
US-20220289800-A1 HV1 MODULATORS AND USES UNIV CALIFORNIA (US) 2022-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042807-A1 NEXT GENERATION ACTX PEPTIDES CRYAA, RNGTT, CALML3 NPY2R 3324/4885NPY4R 3338/4885NPY5R 3579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback